DiaSorin stock steadies as Italy quote holds near EUR 73.80

Published on 09/11/2026 at 18:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

DiaSorin stock traded at EUR 73.80 on September 11, 2026, after a 0.27 percent move. Borsa Italiana also showed EUR 73.60 as the prior-day reference.

Techniker im Reinraum bedienen automatisierte Diagnostikgeräte in modernem Biotech-Labor — Modernes Diagnostiklabor von DiaSorin S.p.A., ISIN IT0003497168, zeigt präzise Biotech-Produktion und klinische Fertigung, Illustration mit AI erstellt.

DiaSorin stock (ISIN IT0003497168) traded at EUR 73.80 on September 11, 2026, after a 0.27 percent rise from the prior-day reference of EUR 73.60. Borsa Italiana's daily performance table gave the Milan-listed group that quote in the FTSE MIB session.

Pricing stays visible

That level kept DiaSorin close to the top of the large-cap screen on the day, even as the broader FTSE MIB moved in the same session. The exchange table also placed the stock alongside other index names such as Campari and Enel on September 11, 2026.

Analyst view and guidance

According to OraFinanza on September 11, 2026, Equita kept a hold rating on DiaSorin and left the target price at EUR 70. According to OraFinanza, Deutsche Bank also cut its target price to EUR 65 from EUR 74 while keeping hold.

That leaves the Milan diagnostics group with a share price above both cited targets on the same day, a gap of EUR 3.80 to Equita and EUR 8.80 to Deutsche Bank. For investors, the current debate is less about the chart and more about how quickly guidance and valuation can catch up.

Price versus targets

DiaSorin stock changed hands at EUR 73.80 on September 11, 2026, with a prior reference at EUR 73.60. The spread to the two cited analyst targets leaves the stock 5.4 percent above EUR 70 and 13.7 percent above EUR 65.